analyst
NA
NASDAQ · NAMS
NewAmsterdam Pharma Company N.V.
Healthcare · Biotechnology
$21.58
Up+$0.32 (+1.48%)
Updated Oct 12, 2026, 11:51 AM
SID Score
3.8/10
Composite research score
Smart Money
58/100
Neutral
- Market cap
- 4.1B
- P/E ratio
- -19.49
- Dividend yield
- 0.00%
- 52-week range
- $20.91 – $42.21
- Volume
- 1.27M
- Avg. volume
- 1.15M
Price performance · NAMS
NAMS price history
1M range · 20 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
NAMS closed at $21.58 after 20 trading sessions, down 3.51% for the selected period.
- Last close
- $21.58
- Period change
- -3.51%
- Period low
- $21.16
- Period high
- $24.32
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $21.25 | $21.79 | $21.02 | $21.575 | 1.27M |
| Oct 8, 2026 | $22.00 | $22.13 | $20.91 | $21.26 | 1.67M |
| Oct 7, 2026 | $22.07 | $22.72 | $21.85 | $22.13 | 1.38M |
| Oct 6, 2026 | $23.06 | $23.11 | $21.4442 | $22.27 | 1.27M |
| Oct 5, 2026 | $22.84 | $23.34 | $22.23 | $22.80 | 1.18M |
| Oct 2, 2026 | $24.60 | $24.75 | $22.67 | $23.20 | 1.55M |
| Oct 1, 2026 | $24.23 | $24.835 | $24.06 | $24.16 | 1.63M |
| Sep 30, 2026 | $24.00 | $25.12 | $23.96 | $24.32 | 2.27M |
| Sep 29, 2026 | $23.52 | $24.54 | $23.26 | $23.81 | 1.08M |
| Sep 28, 2026 | $22.50 | $24.21 | $22.25 | $23.58 | 2.06M |
| Sep 25, 2026 | $22.93 | $22.96 | $22.35 | $22.58 | 1.14M |
| Sep 24, 2026 | $22.47 | $23.19 | $21.95 | $22.74 | 1.82M |
| Sep 23, 2026 | $23.31 | $23.32 | $22.08 | $22.68 | 2.27M |
| Sep 22, 2026 | $22.91 | $23.725 | $22.13 | $23.32 | 2.87M |
| Sep 21, 2026 | $22.95 | $23.20 | $21.68 | $22.58 | 3.53M |
| Sep 18, 2026 | $21.62 | $22.50 | $21.29 | $22.49 | 2.08M |
| Sep 17, 2026 | $21.59 | $23.1125 | $21.455 | $21.93 | 2.31M |
| Sep 16, 2026 | $22.07 | $22.15 | $21.02 | $21.18 | 1.24M |
| Sep 15, 2026 | $22.32 | $22.6247 | $21.08 | $21.16 | 1.73M |
| Sep 14, 2026 | $22.96 | $22.96 | $22.34 | $22.36 | 1.08M |
Latest NAMS news
The latest Smart Investors Daily articles mentioning NAMS.
Stock researchCompany · Forecast
Company
Market Activity
Research & News
Loading stock research…